The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis
Open accessAbstract
Innate immune activation contributes to the transition from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH). Stimulator of IFN genes (STING, also referred to Tmem173) is a universal receptor that recognizes released DNA and triggers innate immune activation. In this work, we investigated the role of STING in the progression of NASH in mice. Both methionine- and choline-deficient diet (MCD) and high-fat diet (HFD) were used to induce NASH in mice. Strikingly, STING deficiency attenuated steatosis, fibrosis, and inflammation in livers in both murine models of NASH. Additionally, STING deficiency increased fasting glucose levels in mice independently of insulin, but mitigated HFD-induced insulin resistance and weight gain and reduced levels of cholesterol, triglycerides, and LDL in serum; it also enhanced levels of HDL. The mitochondrial DNA (mtDNA) from hepatocytes of HFD-fed mice induced TNF-α and IL-6 expression in cultured Kupffer cells (KCs), which was attenuated by STING deficiency or pretreatment with BAY11-7082 (an NF-κB inhibitor). Finally, chronic exposure to 5,6-dimethylxanthenone-4-acetic acid (DMXAA, a STING agonist) led to hepatic steatosis and inflammation in WT mice, but not in STING-deficient mice. We proposed that STING functions as an mtDNA sensor in the KCs of liver under lipid overload and induces NF-κB-dependent inflammation in NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lood, C., Blanco, L. P., Purmalek, M. M., Carmona-Rivera, C., De Ravin, S. S., Smith, C. K., Malech, H. L., Ledbetter, J. A., Elkon, K. B., & Kaplan, M. J. (2016) · Nature Medicine · doi:10.1038/nm.4027 · Cited by 1,570
Mitochondrial DNA in innate immune responses and inflammatory pathology
West, A. P., & Shadel, G. S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.21 · Cited by 1,115 · cited 1×
“Recently, the mitochondrial DNA (mt DNA) has been recognized as one of the endogenous DAMPs when released into the cytosol and extracellular environment, activating innate immune response and promoting inflammation (4, 5).”
BackgroundNew trends on obesity and NAFLD in Asia
Fan, J.-G., Kim, S.-U., & Wong, V. W.-S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.003 · Cited by 1,083
Zhang, X., Shi, H., Wu, J., Zhang, X., Sun, L., Chen, C., & Chen, Z. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.022 · Cited by 1,071
Koliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983 · cited 1×
“In addition to interacting with the TLR9 pathway, mtDNA could also be detected by stimulator of IFN genes–dependent (STING-dependent, STING, also referred to as Tmem173, MPYS, MITA, and ERIS) cytosolic sensors (9, 10).”
BackgroundApoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA
Rongvaux, A., Jackson, R., Harman, C. C. D., Li, T., West, A. P., de Zoete, M. R., Wu, Y., Yordy, B., Lakhani, S. A., Kuan, C.-Y., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.037 · Cited by 847
Paludan, S. R., & Bowie, A. G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.004 · Cited by 759
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613 · cited 1×
“Macrophage-derived TNF-α enhanced the survival of activated hepatic stellate cells (HSCs) and thereby increased liver fibrosis (32).”
BackgroundSauer, J.-D., Sotelo-Troha, K., von Moltke, J., Monroe, K. M., Rae, C. S., Brubaker, S. W., Hyodo, M., Hayakawa, Y., Woodward, J. J., Portnoy, D. A., et al. (2011) · Infection and Immunity · doi:10.1128/iai.00999-10 · Cited by 539
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Malhi, H., & Gores, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091980 · Cited by 538
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
Garcia-Martinez, I., Santoro, N., Chen, Y., Hoque, R., Ouyang, X., Caprio, S., Shlomchik, M. J., Coffman, R. L., Candia, A., & Mehal, W. Z. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83885 · Cited by 498
Innate Immunity and Inflammation in NAFLD/NASH
Arrese, M., Cabrera, D., Kalergis, A. M., & Feldstein, A. E. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4049-x · Cited by 492
Rinella, M. E., & Green, R. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.09.020 · Cited by 460
Petrasek, J., Iracheta-Vellve, A., Csak, T., Satishchandran, A., Kodys, K., Kurt-Jones, E. A., Fitzgerald, K. A., & Szabo, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308331110 · Cited by 452
Tosello-Trampont, A.-C., Landes, S. G., Nguyen, V., Novobrantseva, T. I., & Hahn, Y. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417014 · Cited by 415
Animal models of NASH: Getting both pathology and metabolic context right
Larter, C. Z., & Yeh, M. M. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05543.x · Cited by 337
Mao, Y., Luo, W., Zhang, L., Wu, W., Yuan, L., Xu, H., Song, J., Fujiwara, K., Abe, J.-I., LeMaire, S. A., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309017 · Cited by 306
Self-citationPivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression
Miyao, M., Kotani, H., Ishida, T., Kawai, C., Manabe, S., Abiru, H., & Tamaki, K. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.95 · Cited by 254
Qiao, J. T., Cui, C., Qing, L., Wang, L. S., He, T. Y., Yan, F., Liu, F. Q., Shen, Y. H., Hou, X. G., & Chen, L. (2018) · Metabolism · doi:10.1016/j.metabol.2017.09.010 · Cited by 238
Endo, M., Masaki, T., Seike, M., & Yoshimatsu, H. (2007) · PubMed · Cited by 225
Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection
Thomsen, M. K., Nandakumar, R., Stadler, D., Malo, A., Valls, R. M., Wang, F., Reinert, L. S., Dagnæs‐Hansen, F., Hollensen, A. K., Mikkelsen, J. G., et al. (2016) · Hepatology · doi:10.1002/hep.28685 · Cited by 186
Yang, G., Lee, H. E., & Lee, J. Y. (2016) · Scientific Reports · doi:10.1038/srep24399 · Cited by 170
Wang, X.-A., Zhang, R., She, Z.-G., Zhang, X.-F., Jiang, D.-S., Wang, T., Gao, L., Deng, W., Zhang, S.-M., Zhu, L.-H., et al. (2014) · Hepatology · doi:10.1002/hep.26751 · Cited by 159
Iracheta‐Vellve, A., Petrasek, J., Gyöngyösi, B., Satishchandran, A., Lowe, P., Kodys, K., Catalano, D., Calenda, C. D., Kurt‐Jones, E. A., Fitzgerald, K. A., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.736991 · Cited by 156
Cho, C., Park, H., Ho, A., Semple, I. A., Kim, B. Y., Jang, I., Park, H., Reilly, S. M., Saltiel, A. R., & Lee, J. H. (2017) · Hepatology · doi:10.1002/hep.29742 · Cited by 137
STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus
Guo, F., Han, Y., Zhao, X., Wang, J., Liu, F., Xu, C., Wei, L., Jiang, J., Block, T. M., Guo, J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04321-14 · Cited by 130
Self-citationWilly, J. A., Young-Baird, S. K., Stevens, J. L., Masuoka, H. C., & Wek, R. C. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-01-0036 · Cited by 127
cGAS-mediated autophagy protects the liver from ischemia-reperfusion injury independently of STING
Lei, Z., Deng, M., Yi, Z., Sun, Q., Shapiro, R. A., Xu, H., Li, T., Loughran, P., Griepentrog, J. E., Huang, H., et al. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00326.2017 · Cited by 125
Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease
Wenfeng, Z., Wu, Y., Di, M., Jianping, G., Wu, C., & Huang, C. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31247-5 · Cited by 118
Doğusan, Z., García, M., Flamez, D., Alexopoulou, L., Goldman, M., Gysemans, C. A., Mathieu, C., Libert, C., Eizirik, D. L., & Rasschaert, J. (2008) · Diabetes · doi:10.2337/db07-0844 · Cited by 102
Blaauboer, S. M., Gabrielle, V. D., & Jin, L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301812 · Cited by 73
Vida, M., Gavito, A., Pavón, F. J., Bautista, D., Serrano, A., Suárez, J., Arrabal, S., Decara, J. M., Cuevas, M. R., de Fonseca, F. R., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019166 · Cited by 57
Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases
García‐Martinez, I., Shaker, M. E., & Mehal, W. Z. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6383 · Cited by 47
Zeng, T., Liu, F.-M., Zhou, J., Pan, S.-X., Xia, W., & Chen, L. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0046 · Cited by 38
Dembek, A., Laggai, S., Kessler, S. M., Czepukojc, B., Simon, Y., Kiemer, A. K., & Hoppstädter, J. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.01.003 · Cited by 32
Guo, X., Shu, C., Li, H., Pei, Y., Woo, S., Zheng, J., Liu, M., Xu, H., Botchlett, R. E., Guo, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05884-y · Cited by 31
Park, S. Y., Lee, S. W., Lee, W. S., Rhim, B. Y., Lee, S. J., Kwon, S., Hong, K. W., & Kim, C. D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.017 · Cited by 28
Yang, Y., Huang, Y., Tsai, T., Hou, M., Lee, F., Lee, S., & Lin, H. (2012) · Clinical Science · doi:10.1042/cs20110572 · Cited by 12
Cited by
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Decout, A., Katz, J. D., Venkatraman, S., & Ablasser, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00524-z · Cited by 2,309
Molecular mechanisms and cellular functions of cGAS–STING signalling
Hopfner, K.-P., & Hornung, V. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0244-x · Cited by 2,052
cGAS in action: Expanding roles in immunity and inflammation
Ablasser, A., & Chen, Z. J. (2019) · Science · doi:10.1126/science.aat8657 · Cited by 1,077
Xian, H., Watari, K., Sanchez-Lopez, E., Offenberger, J., Onyuru, J., Sampath, H., Ying, W., Hoffman, H. M., Shadel, G. S., & Karin, M. (2022) · Immunity · doi:10.1016/j.immuni.2022.06.007 · Cited by 850
Wen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Metadata
- Authors
- Yu, Y., Liu, Y., An, W., Song, J., Zhang, Y., & Zhao, X.
- Venue
- Journal of Clinical Investigation
- Published
- 2018-12-18
- Volume
- 129
- Issue
- 2
- Pages
- 546-555
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2905091095
- Cited by
- 383
- References
- 40
- FWCI
- 19.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.